Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001857472 | SCV002171448 | uncertain significance | not provided | 2021-06-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with autosomal recessive retinitis pigmentosa (PMID: 25324289, 30718709). ClinVar contains an entry for this variant (Variation ID: 143066). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 526 of the PDE6B protein (p.Glu526Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. |
Dept Of Ophthalmology, |
RCV003888537 | SCV004705782 | likely pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Department of Ophthalmology and Visual Sciences Kyoto University | RCV000132574 | SCV000172516 | probable-pathogenic | Retinitis pigmentosa | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. | |
Department of Clinical Genetics, |
RCV000132574 | SCV000926629 | likely pathogenic | Retinitis pigmentosa | 2018-04-01 | no assertion criteria provided | research |